258 related articles for article (PubMed ID: 22561729)
21. HIV postexposure prophylaxis: new recommendations.
Patrick DM
CMAJ; 1997 Jan; 156(2):233-4. PubMed ID: 9012728
[No Abstract] [Full Text] [Related]
22. PHS guidelines for management of occupational exposure to HBV, HCV and HIV: HIV postexposure prophylaxis regimens.
Preboth M;
Am Fam Physician; 2002 Jan; 65(2):322, 324-5. PubMed ID: 11820492
[No Abstract] [Full Text] [Related]
23. Management of sharps injuries in the healthcare setting.
Riddell A; Kennedy I; Tong CY
BMJ; 2015 Jul; 351():h3733. PubMed ID: 26223519
[No Abstract] [Full Text] [Related]
24. Post-exposure prophylaxis with a maraviroc-containing regimen after occupational exposure to a multi-resistant HIV-infected source person.
Méchai F; Quertainmont Y; Sahali S; Delfraissy JF; Ghosn J
J Med Virol; 2008 Jan; 80(1):9-10. PubMed ID: 18041046
[TBL] [Abstract][Full Text] [Related]
25. HIV seroconversion in a health care worker who underwent postexposure prophylaxis following needlestick injury.
Borba Brum MC; Dantas Filho FF; Yates ZB; Verçoza Viana MC; Martin Chaves EB; Trindade DM
Am J Infect Control; 2013 May; 41(5):471-2. PubMed ID: 23084562
[No Abstract] [Full Text] [Related]
26. Challenges in HIV post-exposure prophylaxis for occupational injuries in a large teaching hospital in Malawi.
van Oosterhout JJ; Nyirenda M; Beadsworth MB; Kanyangalika JK; Kumwenda JJ; Zijlstra EE
Trop Doct; 2007 Jan; 37(1):4-6. PubMed ID: 17326876
[TBL] [Abstract][Full Text] [Related]
27. Postexposure prophylaxis for HIV.
Chin RL
Emerg Med Clin North Am; 2010 May; 28(2):421-9, Table of Contents. PubMed ID: 20413023
[TBL] [Abstract][Full Text] [Related]
28. Occupational HIV exposure.
Mileno MD
Med Health R I; 2000 Jul; 83(7):207-10. PubMed ID: 10934822
[No Abstract] [Full Text] [Related]
29. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group.
Cardo DM; Culver DH; Ciesielski CA; Srivastava PU; Marcus R; Abiteboul D; Heptonstall J; Ippolito G; Lot F; McKibben PS; Bell DM
N Engl J Med; 1997 Nov; 337(21):1485-90. PubMed ID: 9366579
[TBL] [Abstract][Full Text] [Related]
30. [Postexposure prophylaxis after occupational exposure to HBV, HCV and HIV].
Sarrazin U; Brodt R; Sarrazin C; Zeuzem S
Radiologe; 2004 Feb; 44(2):181-94. PubMed ID: 14991139
[TBL] [Abstract][Full Text] [Related]
31. [Serologic testing after needlestick incidents in hospitals. A questionnaire study].
Graversen M; Bytzer P
Ugeskr Laeger; 2004 Feb; 166(7):592-5. PubMed ID: 15005043
[No Abstract] [Full Text] [Related]
32. Tolerability of HIV postexposure prophylaxis among healthcare workers.
Kiertiburanakul S; Wannaying B; Tonsuttakul S; Kehachindawat P; Apivanich S; Somsakul S; Malathum K
J Hosp Infect; 2006 Jan; 62(1):112-4. PubMed ID: 16099546
[No Abstract] [Full Text] [Related]
33. Bloodborne pathogens: a new threat.
Corbin DE
J Healthc Prot Manage; 2000; 16(2):119-23. PubMed ID: 11183169
[No Abstract] [Full Text] [Related]
34. [Prophylaxis after occupational exposure to HIV].
Torten D; Bentwich Z
Harefuah; 2000 Apr; 138(8):671-7. PubMed ID: 10883211
[No Abstract] [Full Text] [Related]
35. Infection control special report. After the needlestick.
Fraser VJ
Mater Manag Health Care; 1998 Aug; 7(8):30, 32, 34. PubMed ID: 10182680
[No Abstract] [Full Text] [Related]
36. HIV post-exposure prophylaxis (PEP)--effect on management of bloodborne pathogen exposures in the health care environment.
DesRoches P
AAOHN J; 2003 Sep; 51(9):370-2. PubMed ID: 14510031
[No Abstract] [Full Text] [Related]
37. Post-exposure prophylaxis:access and fairness.
Peate I
Br J Nurs; 2006 Oct 12-25; 15(18):968. PubMed ID: 17077766
[No Abstract] [Full Text] [Related]
38. Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis for 2 health care workers.
Johnson S; Baraboutis JG
JAMA; 2000 Dec; 284(21):2722-3. PubMed ID: 11105175
[No Abstract] [Full Text] [Related]
39. HIV, occupational exposure, and medical responsibilities.
Lafeuillade A; Thiebaut C; Quilichini R; Profizi N
Lancet; 1995 Aug; 346(8974):579-80. PubMed ID: 7658804
[No Abstract] [Full Text] [Related]
40. Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis for 2 health care workers.
Sha BE; Proia LA; Kessler HA
JAMA; 2000 Dec; 284(21):2723. PubMed ID: 11105176
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
